Meyer Fedida’s practice focuses on U.S. federal tax matters, with a particular emphasis on complex M&A transactions and joint ventures, private equity fund formation, and cross-border tax planning.

Meyer joined the firm in 2003 and became partner in 2015. He was previously resident in the London office.

Notable Experience

Corporate M&A

  • Synopsys in its pending $35 billion acquisition of Ansys and in its pending up to $2.1 billion sale of its Software Integrity business.

  • Disney in the pending $8.5 billion merger of Star India with Viacom18 to form a new joint venture with Reliance.

  • T-Mobile in its pending $4.4 billion acquisition of UScellular’s wireless operations and select spectrum assets, and in its $1.35 billion acquisition of Ka’ena and its subsidiaries and brands, Mint Mobile, Ultra Mobile, and Plum.

  • Artémis in its acquisition of a majority stake in CAA from TPG.

  • Roquette in its pending acquisition of IFF’s Pharma Solutions business.

  • Cascade Investment in its $4.7 billion acquisition of Signature Aviation (as part of a consortium with Blackstone and Global Infrastructure Partners).

  • National Amusements (the Redstone family holding company) with respect to its investments in CBS and Viacom, including the $30.5 billion merger of CBS and Viacom.

  • General Motors in the sale of its Opel/Vauxhall subsidiaries and European financial operations to PSA Group.

  • Google in numerous transactions, including its pending sale of the assets of its Google Domains business to Squarespace and its acquisition of Raxium.

  • Solvay SA in the spin-off and listing of Syensqo (initial market capitalization of app. €9.5 billion).

  • Thales in its $3.6 billion acquisition of Imperva, its €4.8 billion tender offer for Gemalto, and its related divestment of its General Purpose Hardware Security Module business to Entrust.

  • GlaxoSmithKline in its announced up to $1.4 billion acquisition of Aiolos, and its $1.9 billion acquisition of Sierra Oncology.

  • Kindred Healthcare in its $4.1 billion sale to a consortium comprising TPG, Welsh Carson Anderson & Stowe, and Humana, and in its $1.8 billion acquisition of Gentiva Health Services.

  • LATAM Airlines in its $1.9 billion strategic partnership with Delta.

  • BNP Paribas in its novel transaction in relation to Deutsche Bank’s global prime brokerage and electronic equities businesses, and in its acquisition of Deutsche Bank’s Delta One hedge derivatives book.

  • Donatella Versace, GiVi Holding, and Jonathan Akeroyd in the $2.13 billion sale of Versace to Michael Kors.

  • Lafarge in its €40 billion merger of equals with Holcim to create LafargeHolcim.

  • Takeda Pharmaceutical Co. in its $5.2 billion acquisition of ARIAD Pharmaceuticals.

  • BHP Billiton in the demerger of South 32 (initial capitalization of $9.1 billion).

  • Alstom in its €6.2 billion acquisition of Bombardier Transportation.

  • Cohu in its acquisition of Xcerra.

  • Safran in the sale of its identity and security activities (Safran I&S) for €2.425 billion.

  • Amundi in its €3.5 billion acquisition of Pioneer Investments from UniCredit.

  • Merck & Co. in its joint venture with Sanofi Pasteur for the exploitation of hexavalent vaccine Vaxelis.

  • ABB in its cable tray joint venture with Niedax and its acquisition of Siemens’ low voltage NEMA motor business.

  • Evraz Group S.A. in its $4 billion acquisition of IPSCO Inc. and simultaneous divestiture of certain of the purchased assets.

  • MEDNAX in its sales of American Anesthesiology to North American Partners in Anesthesia and MedData to Frazier Healthcare Partners.

  • Saint-Gobain in its C$1.325 billion acquisition of Building Products of Canada and its $928 million acquisition of Kaycan.

  • Sysco in its acquisition of Greco and Sons and of The Coastal Companies.

  • Johnson Controls in its acquisition of workplace management software leader FM:Systems.

See More

Private Equity M&A

  • TPG (and its portfolio companies) in connection with various transactions including:

    • Astound Broadband in its sale to Stonepeak Infrastructure Partners for $8.1 billion.
    • TPG in its $1.3 billion sale of United Family Healthcare.
    • RCN Telecom Services in its $2.36 billion acquisition of Wave Broadband;
    • Cushman & Wakefield in its IPO and pre-IPO restructuring and previously DTZ in the $2 billion acquisition of Cushman & Wakefield, and TPG, PAG, and OTPP in the $1.2 billion acquisition of DTZ from UGL and of Cassidy Turley;
    • Envision Pharmaceutical Holdings (a national, full-service pharmacy benefit management company) in its $2 billion sale to Rite Aid (and TPG in its prior acquisition of Envision Pharmaceutical Holdings); and
    • TPG in its investments in Uber.
  • Warburg Pincus in several transactions.

  • Carlyle Global Partners in several transactions.

  • Sequoia and Paradigm in their $1.15 billion minority investment in Citadel Securities.

  • Groupe Marc de Lacharrière (the family holding company of Marc Ladreit de Lacharrière) in its investment resulting in a 5% stake in private equity firm Warburg Pincus.

See More

Private Equity Fund Formation

  • TPG in a wide range of fund matters, including the formation and operation of its private equity, social impact, and other specialty funds, including TPG Partners V, VI, VII, VIII, and IX; TPG Healthcare Partners I and II; TPG Growth II, III, IV, and V; The Rise Fund I and II; and TPG Asia V, VI, VII, and VIII.

  • The Blackstone Group and Blackstone Alternative Asset Management in connection with various investment funds, including Blackstone Life Sciences Yield and Blackstone Life Sciences Fund V.

  • The Carlyle Group in connection with various investment funds.

  • Sequoia Capital in fund formation matters and in a number of investments in private funds.

  • Regular advisor to various large family offices and private foundations in their private equity investments.

See More

Selected Activities


Member, Tax Section Executive Committee, New York State Bar Association; Co-Chair Committee on Partnerships

Member, Tax Forum

Member, New York Private Investment Funds Tax Forum